blfs_8k.htm


SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549
______________________________

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

April 6, 2011
Date of report (Date of earliest event reported)
____________________________________

BIOLIFE SOLUTIONS, INC.
(Exact Name of Registrant as Specified in Charter)
 
Delaware     0-18710   94-3076866
(State or Other Jurisdiction of Incorporation)   (Commission File No.)    (IRS Employer Identification No.)
 
3303 Monte Villa Parkway, Bothell, WA 98021
(Address of principal executive offices, including zip code)

(425) 402-1400
(Registrant’s telephone number, including area code)
____________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
£
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
£
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
£
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
£
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))



 
 

 
 
ITEM 8.01.   OTHER EVENTS
 
On April 6, 2011, the Company issued the press release attached hereto as Exhibit 9.01(d).
 
ITEM 9.01.  FINANCIAL STATEMENTS AND EXHIBITS
 
(d)   Press release dated April 6, 2011.
 
 
2

 

 
SIGNATURES:

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
  BIOLIFE SOLUTIONS, INC.  
       
Date:  April 6, 2011
By:
/s/Mike Rice     
    Mike Rice  
   
President and Chief Executive Officer
(Principal Executive Officer)
 
       

 
3